- Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumoursAndre Albergaria
Development Domain, Institute of Life and Health Sciences ICVS, School of Health Sciences of Minho University, Campus de Gualtar, Braga, Portugal
Breast Cancer Res 11:R40. 2009..The purpose of this study was to explore if the expression of FOXA1 and GATA-3 may provide an opportunity to stratify subsets of patients that could have better outcome, among the ERalpha-negative/poor prognosis breast cancer group...
- Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesionsNair Lopes
Institute of Molecular Pathology and Immunology of the University of Porto, Porto 4200 465, Portugal
BMC Cancer 10:483. 2010..We aimed to study the expression of these three proteins by immunohistochemistry in a series of breast lesions...